Discovery Laboratories Inc. (NASDAQ:WINT)’s share price gapped up before the market opened on Friday . The stock had previously closed at $2.64, but opened at $2.65. Discovery Laboratories shares last traded at $3.07, with a volume of 2,013,497 shares changing hands.

WINT has been the topic of several research analyst reports. HC Wainwright initiated coverage on shares of Discovery Laboratories in a report on Friday, April 22nd. They set a “buy” rating and a $8.00 price target on the stock. Zacks Investment Research cut shares of Discovery Laboratories from a “buy” rating to a “hold” rating in a report on Thursday, July 21st.

The firm’s market capitalization is $24.26 million. The stock has a 50 day moving average price of $2.02 and a 200 day moving average price of $2.19.

Discovery Laboratories (NASDAQ:WINT) last posted its earnings results on Wednesday, August 10th. The company reported ($1.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.64) by $0.35. On average, equities analysts anticipate that Discovery Laboratories Inc. will post ($5.87) EPS for the current fiscal year.

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.